¥4823.00
+
¥143.00 (2.96%)
End-of-day quote: 05/15/2024
TSE:4519
Chugai Pharmaceutical Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $771.12 | $636.99 | 0.00% | 9 | $694.32B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.28 | $174.55 | 0.00% | 3 | $371.30B |
| ABBV | AbbVie | NYSE | Outperform | $164.35 | $178.42 | 0.00% | 11 | $290.22B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.66 | £165.99 | 0.00% | 16 | £188.60B |
| ROG | Roche Holding | SWX | Hold | CHF234.80 | CHF307.83 | 0.00% | 9 | CHF189.54B |
| PFE | Pfizer | NYSE | Outperform | $28.92 | $32.87 | 0.00% | 6 | $163.88B |
| SAN | Sanofi | ENXTPA | Outperform | 90.24€ | 102.80€ | 0.00% | 9 | 112.81€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $967.98 | $961.26 | 0.00% | 8 | $104.43B |
| GSK | GSK | LSE | Outperform | £17.84 | £17.30 | 0.00% | 12 | £72.73B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.11 | $58.15 | 0.00% | 10 | $89.42B |
